Table 1.
n | 72 |
Age (years) | 46.2 ± 1.8 |
Sex (male/female) | 39/33 |
BMI (kg/m2) | 29.9 ± 1.2 |
Fasting plasma glucose (mg/dL) | 111 ± 2 |
2 h glucose (mg/dL) | 208 ± 9 |
Basal insulin (μU/mL) | 14.0 ± 1.2 |
Insulinogenic index [(μU/mL)/(mg/dL)] | 0.77 ± 0.10 |
HOMA-IR | 3.8 ± 0.3 |
Matsuda index | 2.8 ± 0.2 |
Hepatic insulin resistance index × 106 | 5.9 ± 0.5 |
HbA1c (%) | 6.8 ± 0.2 |
Total cholesterol (mg/dL) | 200 ± 4 |
Triglycerides (mg/mL) | 140 ± 9 |
HDL cholesterol (mg/mL) | 46 ± 1 |
Aspartate aminotransferase (IU/L) | 44 ± 3 |
Alanine aminotransferase (IU/L) | 72 ± 7 |
Historogical scores | |
Stage (0/1/2/3/4) | 2/17/20/7/6 |
Grade (0/1/2/3) | 37/16/14/5 |
Steatosis (0/1/2/3) | 0/31/23/18 |
Statin (+/−) | 17/55 |
Angiotensin receptor blocker (+/−) | 13/59 |
Insulin (+/−) | 17/55 |
BMI, body mass index; HbA1c, hemoglobin A1c; HDL cholesterol, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance. Data are presented as mean ± standard error of the mean or absolute numbers.